Identification of inhibitors of HIF2a as modulators of the hypoxia response for the treatment of cancer

被引：0

作者：

Johnstone, Shawn ^{[1
]}

Albert, Jeffrey

Coupal, Martin ^{[2
]}

Lee, Stephen ^{[3
]}

机构：

[1] IntelliSyn Pharma, Chem, Montreal, PQ, Canada

[2] IntelliSyn Pharma, Biol, Montreal, PQ, Canada

[3] Univ Miami, Dept Biochem & Mol Biol, Miami, FL 33101 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 250卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

173

引用

页数：1

共 50 条

[41] Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element [J].

Xu, J. ;

Wang, B. ;

Xu, Y. ;

Sun, L. ;

Tian, W. ;

Shukla, D. ;

Barod, R. ;

Grillari, J. ;

Grillari-Voglauer, R. ;

Maxwell, P. H. ;

Esteban, M. A. .

ONCOGENE, 2012, 31 (08) :1065-1072

[42] Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element [J].

J Xu ;

B Wang ;

Y Xu ;

L Sun ;

W Tian ;

D Shukla ;

R Barod ;

J Grillari ;

R Grillari-Voglauer ;

P H Maxwell ;

M A Esteban .

Oncogene, 2012, 31 :1065-1072

[43] Modulators of HIF1αand NFkB in cancer treatment: is it a rational approach for controlling malignant progression? [J].

Tafani, Marco ;

Pucci, Bruna ;

Russo, Andrea ;

Schito, Luana ;

Pellegrini, Laura ;

Perrone, Giulietta A. ;

Villanova, Lidia ;

Salvatori, Luisa ;

Ravenna, Linda ;

Petrangeli, Elisa ;

Russo, Matteo A. .

FRONTIERS IN PHARMACOLOGY, 2013, 4

[44] Transcriptional activation of the Prox1 gene by HIF-1α and HIF-2α in response to hypoxia [J].

Zhou, Bisheng ;

Si, Wenxia ;

Su, Zhenhong ;

Deng, Wenbin ;

Tu, Xin ;

Wang, Qing .

FEBS LETTERS, 2013, 587 (06) :724-731

[45] The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy [J].

Albadari, Najah ;

Deng, Shanshan ;

Li, Wei .

EXPERT OPINION ON DRUG DISCOVERY, 2019, 14 (07) :667-682

[46] Discovery and characterization of novel, potent, and selective hypoxia-inducible factor (HIF)-2α inhibitors [J].

Lawson, K. ;

Gauthier, K. Sivick ;

Piovesan, D. ;

Fournier, J. ;

Rosen, B. ;

Maliyan, A. ;

Beatty, J. ;

Jin, L. ;

Leleti, M. ;

Ginn, E. ;

Udyavar, A. ;

Ada, C. ;

Au, J. ;

Meleza, C. ;

Zhao, S. ;

Young, S. ;

Walters, M. ;

Powers, J. .

EUROPEAN JOURNAL OF CANCER, 2020, 138 :S16-S16

[47] PROGNOSTIC IMPACT OF THE EXPRESSION PROFILE OF THE HYPOXIA RELATED GENES CA9, CA12, HIF1A, HIF2A, SCL2A1 AND VEGF IN OSTEOSARCOMA AND EWING SARCOMA [J].

Scrideli, C. A. ;

Franca, M. ;

Engel, E. E. ;

Queiroz, R. G. P. ;

Neder, L. ;

Suazo, V. K. ;

Mori, B. O. ;

Tone, L. G. ;

Scrideli, C. A. .

PEDIATRIC BLOOD & CANCER, 2014, 61 :S275-S276

[48] EHD1 promotes breast cancer metastasis through upregulating HIF2a expression via activating mTOR pathway [J].

Gao, Xiaoqian ;

Li, Juan ;

Feng, Xuefei ;

Xie, Yuchen ;

Zhang, Juan ;

Liu, Jie ;

Wang, Bo ;

Liu, Peijun .

FASEB JOURNAL, 2024, 38 (21)

[49] Targeting both HIF-1 and HIF-2 in human colon cancer cells improves tumor response to sunitinib treatment [J].

Burkitt, Kyunghee ;

Chun, Sang Y. ;

Dang, Duyen T. ;

Dang, Long H. .

MOLECULAR CANCER THERAPEUTICS, 2009, 8 (05) :1148-1156

[50] Modulation of hypoxia-inducible factors and the HIF transcriptional response to hypoxia by ERBB2 overexpression in the MCF7 breast cancer cell line [J].

Jarman, E. J. ;

Turnbull, A. K. ;

Martinez-Perez, C. ;

Meehan, J. ;

Xintralopoulou, C. ;

Ward, C. ;

Langdon, S. P. .

CANCER RESEARCH, 2016, 76

← 1 2 3 4 5 →